Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.aurolabs.com | |
Market Cap | 84.58 Cr. | |
Enterprise Value(EV) | 92.94 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 7.74 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 17.52 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.97 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 59.38 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.29 | Calculated using Price: 135.70 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.62 Cr. | 6,232,500 Shares |
FaceValue | 10 | |
About Auro Laboratories Ltd. | ||
Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah. |
1 Day |
|
|
1 Week |
|
-7.69% |
1 Month |
|
+21.43% |
3 Month |
|
+3.24% |
6 Month |
|
+63.49% |
1 Year |
|
+82.15% |
2 Year |
|
+32.65% |
5 Year |
|
+119.58% |
10 Year |
|
+2268.24% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 11.01 | 10.83 | 9.06 | 31.53 | 28.95 | 20.84 | 28.67 | 9.47 | 7.43 | |
Return on Capital Employed (%) | 10.76 | 11.21 | 20.24 | 28.65 | 29.12 | 24.80 | 38.88 | 12.20 | 9.92 | |
Return on Assets (%) | 2.89 | 3.24 | 3.11 | 12.34 | 13.78 | 12.32 | 19.34 | 5.87 | 4.40 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 8 | 9 | 9 | 13 | 17 | 22 | 29 | 32 | 34 | 37 | |
Non Curr. Liab. | 8 | 7 | 11 | 8 | 6 | 5 | 4 | 3 | 4 | 11 | |
Curr. Liab. | 14 | 10 | 6 | 10 | 10 | 6 | 9 | 20 | 18 | 14 | |
Minority Int. | |||||||||||
Equity & Liab. | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 56 | 62 | |
Non Curr. Assets | 11 | 13 | 13 | 15 | 15 | 14 | 14 | 18 | 21 | 26 | |
Curr. Assets | 18 | 12 | 14 | 16 | 19 | 18 | 28 | 37 | 35 | 36 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 56 | 62 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 33 | 28 | 35 | 41 | 47 | 44 | 54 | 51 | 53 | 53 | |
Other Income | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |
Total Income | 33 | 28 | 36 | 41 | 48 | 45 | 55 | 52 | 54 | 54 | |
Total Expenditure | -30 | -25 | -31 | -34 | -40 | -38 | -43 | -46 | -49 | -46 | |
PBIDT | 3 | 3 | 5 | 7 | 8 | 7 | 12 | 6 | 5 | 9 | |
Interest | -2 | -2 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | -2 | -1 | -2 | -2 | -3 | -1 | -1 | -2 | |||
Exceptional Items | |||||||||||
PAT | 1 | 1 | 1 | 4 | 4 | 4 | 7 | 3 | 2 | 5 | |
Adjusted EPS | 1 | 1 | 1 | 6 | 7 | 7 | 12 | 5 | 4 | 8 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 4 | -1 | 8 | 6 | 5 | 7 | 9 | 13 | -7 | 3 | |
Cash Fr. Inv. | -1 | -1 | -2 | -2 | -2 | -3 | -2 | -4 | -5 | -5 | |
Cash Fr. Finan. | -3 | 1 | -5 | -4 | -2 | -2 | -6 | 0 | 10 | -8 | |
Net Change | 1 | -1 | 0 | 0 | 1 | 2 | 2 | 9 | -2 | -10 | |
Cash & Cash Eqvt | 1 | 0 | 1 | 1 | 2 | 4 | 6 | 15 | 12 | 2 |
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication |
Thu, 09 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Dated November 9 2023 We wish to inform that the Board of directors of our Company in their meeting held today i.e November 9 2023 has considered and approved the unaudited financial results for the quarter and half year ended September 30 2023. |
Thu, 09 Nov 2023
Results For Quarter And Half Year Ended September 30 2023 Results |
Tue, 28 Nov 2023 |
|
|
|
|
|